| 摘要 |
The present invention relates to a method for determining the state of peri-implant disease comprising the steps of quantifying the expression level of one or more regulated markers of a group of markers forming a panel, said one or more regulated markers being related to the plasminogen system and/or inflammation and/or proteolytic activity or combinations thereof or ratios thereof in an ex vivo sample; and determining the state of peri-implant disease by comparing the expression level obtained in step a with a reference value. The present invention also relates to a kit for performing the invention. |
